Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment

[1] Ozdoganoglu T(2012)Quality of life in allergic rhinitis Ther Adv Respir Dis 6 25-39

[2] Songu M(2012)Cost-effectiveness of allergen immunotherapy J Allergy Ther 01 006-568

[3] Inancli HM(2015)International consensus on allergy immunotherapy J Allergy Clin Immunol 136 556-1105

[4] Incorvaia C(2012)The cost-effectiveness of immunotherapy for respiratory allergy: a review Allergy 67 1087-118

[5] Berto P(2015)Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany Clin Transl Allergy 5 1-933

[6] Ariano R(2004)Modelling in the economic evaluation of health care: selecting the appropriate approach J Health Serv Res Policy 9 110-319

[7] Elia R(2010)Methoden der gesundheitsökonomischen Evaluation in der Versorgungsforschung Gesundheitswesen 72 917-917

[8] Frati F(2014)Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, He

[9] Jutel M(2012)Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany J Med Econ 15 906-857

[10] Agache I(2002)Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 251-360.e2

[1] Ozdoganoglu T(2012)Quality of life in allergic rhinitis Ther Adv Respir Dis 6 25-39

[2] Songu M(2012)Cost-effectiveness of allergen immunotherapy J Allergy Ther 01 006-568

[3] Inancli HM(2015)International consensus on allergy immunotherapy J Allergy Clin Immunol 136 556-1105

[4] Incorvaia C(2012)The cost-effectiveness of immunotherapy for respiratory allergy: a review Allergy 67 1087-118

[5] Berto P(2015)Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany Clin Transl Allergy 5 1-933

[6] Ariano R(2004)Modelling in the economic evaluation of health care: selecting the appropriate approach J Health Serv Res Policy 9 110-319

[7] Elia R(2010)Methoden der gesundheitsökonomischen Evaluation in der Versorgungsforschung Gesundheitswesen 72 917-917

[8] Frati F(2014)Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, He

[9] Jutel M(2012)Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany J Med Econ 15 906-857

[10] Agache I(2002)Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 251-360.e2